All Posts

Vitafoods Europe 2023 was a great success, and it provided a valuable opportunity for the nutraceutical and functional ingredients community

Unveil aging secrets with C. elegans. Discover how studying this tiny worm unlocks longevity insights and fights age-related diseases.

Verb Biotics Partners with NemaLife This month NemaLife announced Verb Biotics as a valued partner. We we look forward to working...

The 2023 Future of FoodTech conference was held in San Francisco, from March 16-17, with more than 1500 attendees. This conference...

NemaLife is a 2023 Probiota Pioneer Winner This was our first year at the IPA World Congress + Probiota 2023 event in Barcelona, Spain....

Recently at the IPA World Congress + Probiota 2023 event in Barcelona, I had the opportunity to lead a roundtable discussion on...

Recently, NemaLife was selected as a 2023 Probiota Pioneer, which is an award given to innovative start-ups serving the ever-expanding...

The 2023 IPA World Congress + Probiota, brought to you by NutraIngredients, was a big event in the probiotic industry. Here's the recap.

Addressing market demand for rapid evaluation of novel ingredients, NemaLife enhances the capabilities of its in vivo screening platform....

A startup company providing the nutraceuticals industry with fast and affordable ingredient screening via AI nematode analysis has been...

Loss of muscle mass and strength present a major challenge for astronauts on future long space voyages. Determining Muscle Strength in Space

NemaLife Walks to End Alzheimer's Disease

NemaLife builds nematode-based ingredient screening pipeline for rapid, affordable, and actionable results

NemaLife attends Miami Microbiome Conference

From left to right: Siva Vanapalli, Ph.D., Nicki Vanapalli, Thomas Germain, Tyler Chiriboga, Kylie Harman, Kellen Ketchersid, Adnan...

NemaLife is a techbio company focused on high throughput in vivo screening, is delighted to announce that it has joined the International...

Yesterday, the US Senate unanimously approved the FDA Modernization Act 2.0, which was previously approved by the Lower House. This new...

NemaLife receives funding to develop a neurotherapeutic discovery platform using next-generation psychedelic compounds. LUBBOCK, TX, USA,...

2022 Rising Stars Announced at BioNTX’s iC³ Life Science Summit Rising Star Award Every year BioNTX selects Rising Stars in the life...

NemaLife’s AI-assisted microfluidics-based tech platform receives funding to pursue rapid discovery of drug candidates that could improve...